Critical Survey: Ascend Wellness (AAWH) vs. Its Peers

Ascend Wellness (OTC:AAWHGet Rating) is one of 53 public companies in the “Medicinals & botanicals” industry, but how does it compare to its peers? We will compare Ascend Wellness to similar companies based on the strength of its earnings, profitability, dividends, risk, analyst recommendations, institutional ownership and valuation.

Valuation and Earnings

This table compares Ascend Wellness and its peers top-line revenue, earnings per share (EPS) and valuation.

Gross Revenue Net Income Price/Earnings Ratio
Ascend Wellness $332.38 million -$122.66 million -4.18
Ascend Wellness Competitors $259.30 million -$62.88 million -8.43

Ascend Wellness has higher revenue, but lower earnings than its peers. Ascend Wellness is trading at a higher price-to-earnings ratio than its peers, indicating that it is currently more expensive than other companies in its industry.

Insider & Institutional Ownership

0.0% of Ascend Wellness shares are owned by institutional investors. Comparatively, 16.3% of shares of all “Medicinals & botanicals” companies are owned by institutional investors. 24.9% of Ascend Wellness shares are owned by insiders. Comparatively, 29.8% of shares of all “Medicinals & botanicals” companies are owned by insiders. Strong institutional ownership is an indication that hedge funds, endowments and large money managers believe a stock will outperform the market over the long term.

Profitability

This table compares Ascend Wellness and its peers’ net margins, return on equity and return on assets.

Net Margins Return on Equity Return on Assets
Ascend Wellness -21.49% -33.06% -7.81%
Ascend Wellness Competitors 430.43% -219.40% 104.39%

Analyst Ratings

This is a breakdown of recent recommendations for Ascend Wellness and its peers, as provided by MarketBeat.

Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score
Ascend Wellness 0 0 3 0 3.00
Ascend Wellness Competitors 172 504 642 38 2.40

Ascend Wellness currently has a consensus price target of $9.00, indicating a potential upside of 378.72%. As a group, “Medicinals & botanicals” companies have a potential upside of 159.41%. Given Ascend Wellness’ stronger consensus rating and higher possible upside, analysts clearly believe Ascend Wellness is more favorable than its peers.

Ascend Wellness Company Profile

(Get Rating)

Ascend Wellness Holdings, Inc. engages in the cultivation, manufacture, and distribution of cannabis consumer packaged goods. Its cannabis product categories include flowers, pre-rolls, concentrates, vapes, edibles, and other cannabis-related products. As of December 31, 2021, the company operated 20 retail locations. It also sells its products to third-party licensed cannabis retail stores. The company was incorporated in 2018 and is headquartered in New York, New York.

Receive News & Ratings for Ascend Wellness Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Ascend Wellness and related companies with MarketBeat.com's FREE daily email newsletter.